Citations

Citations to this article as recorded by  

• High glycated albumin is associated with early neurological deterioration in patients with acute ischemic stroke
  Ki-Woong Nam, Jung Hoon Han, Chi Kyung Kim, Hyung-Min Kwon, Yong-Seok Lee, Kyungmi Oh, Keon-Joo Lee, Byeongsu Park
  BMC Neurology.2024;[Epub]     CrossRef
• Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
  Jeongseon Yoo, Youngah Choi, Shin Ae Park, Ji Yeon Seo, Chul Woo Ahn, Jaehyun Han
  Journal of Clinical Medicine.2022; 11(9): 2327.     CrossRef
• Variability in glycated albumin levels predicts the progression of diabetic nephropathy
  Su Bin Park, Sang Soo Kim, In Joo Kim, Yoon Jeong Nam, Kang Hee Ahn, Jong Ho Kim, Yun Kyung Jeon, Bo Hyun Kim, Sang Heon Song, Ihm Soo Kwak, Eun Kyung Lee, Yong Ki Kim
  Journal of Diabetes and its Complications.2017; 31(6): 1041.     CrossRef
• Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease
  Gyuri Kim, Kwang Joon Kim, Yumie Rhee, Sung-Kil Lim, Salvatore Petta
  PLOS ONE.2017; 12(7): e0182202.     CrossRef
• Determinants of Preclinical Atherosclerosis Are Different in Type 1 and Type 2 Diabetic Women
  P. PIŤHOVÁ, K. ŠTECHOVÁ, J. PIŤHA, V. LÁNSKÁ, M. KVAPIL
  Physiological Research.2016; : 219.     CrossRef
• Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
  Gyuri Kim, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  Yonsei Medical Journal.2016; 57(6): 1395.     CrossRef
• Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes
  Gyuri Kim, Kwanhyeong Jo, Kwang Joon Kim, Yong-ho Lee, Eugene Han, Hye-jin Yoon, Hye Jin Wang, Eun Seok Kang, Mijin Yun
  Cardiovascular Diabetology.2015;[Epub]     CrossRef
• Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
  Hye-jin Yoon, Yong-ho Lee, So Ra Kim, Tyler Hyungtaek Rim, Eun Young Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  Cardiovascular Diabetology.2015;[Epub]     CrossRef
• Comparison of Candidate Pairs of Hydrolytic Enzymes for Spectrophotometric-dual-enzyme-simultaneous-assay
  Hongbo Liu, Mei Yuan, Xiaolan Yang, Xiaolei Hu, Juan Liao, Jizheng Dang, Yanling Xie, Jun Pu, Yuanli Li, Chang-Guo Zhan, Fei Liao
  Analytical Sciences.2015; 31(5): 421.     CrossRef
• Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1cwith Time
  Hye-jin Yoon, Yong-ho Lee, Kwang Joon Kim, So Ra Kim, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  BioMed Research International.2015; 2015: 1.     CrossRef
• Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study
  Naoko Mukai, Toshiharu Ninomiya, Jun Hata, Yoichiro Hirakawa, Fumie Ikeda, Masayo Fukuhara, Taeko Hotta, Masafumi Koga, Udai Nakamura, Dongchon Kang, Takanari Kitazono, Yutaka Kiyohara
  Cardiovascular Diabetology.2015;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review
  Xueqin Xie, Changchun Wu, Yuduo Hao, Tianyu Wang, Yuhe Yang, Peiling Cai, Yang Zhang, Jian Huang, Kejun Deng, Dan Yan, Hao Lin
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Estimation of Serum Creatinine, Aspartate Aminotransferase, Alanine Transaminase, and Hemoglobin A1c% Levels among Diabetic Patients using Metformin/Dipeptide Peptidase-4 Inhibitor Combination and Insulin – A Cross-Sectional Study
  Arshiya Shadab, Ilma Hussain, Praveen Kumar Kandakurti, Marwan Ismail, Ahmed Luay Osman Hashim, Salah Eldin Omar Hussein, Altoum Abd Elgadir
  Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 959.     CrossRef
• Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
  Hae Kyung Yang, Seung-Hwan Lee, Juyoung Shin, Yoon-Hee Choi, Yu-Bae Ahn, Byung-Wan Lee, Eun Jung Rhee, Kyung Wan Min, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2019; 43(3): 287.     CrossRef
• Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia
  Manoj Chawla, Tae Ho Kim, Roberto C. Mirasol, Pathan Faruque, Kathryn Cooke, Peggy Hours-Zesiger, Abhijit Shete
  Current Medical Research and Opinion.2018; 34(9): 1605.     CrossRef
• Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force
  Sanjay Kalra, Silver Bahendeka, Rakesh Sahay, Sujoy Ghosh, Fariduddin Md, Abbas Orabi, Kaushik Ramaiya, Sameer Al Shammari, Dina Shrestha, Khalid Shaikh, Sachitha Abhayaratna, PradeepK Shrestha, Aravinthan Mahalingam, Mazen Askheta, AlyAhmed A. Rahim, Fat
  Indian Journal of Endocrinology and Metabolism.2018; 22(1): 132.     CrossRef
• Efficacy and safety of sitagliptin/metformin fixed‐dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double‐blind study
  Sang Soo Kim, In Joo Kim, Kwang Jae Lee, Jeong Hyun Park, Young Il Kim, Young Sil Lee, Sung Chang Chung, Sang Jin Lee
  Journal of Diabetes.2017; 9(4): 412.     CrossRef
• Short‐term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9%
  Jianping Weng
  Journal of Diabetes.2017; 9(10): 890.     CrossRef
• The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
  Gyuri Kim, Sewon Oh, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee
  Expert Opinion on Pharmacotherapy.2017; 18(12): 1179.     CrossRef
• Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis
  Elena Filipova, Katya Uzunova, Krassimir Kalinov, Toni Vekov
  Diabetology & Metabolic Syndrome.2017;[Epub]     CrossRef
• Is insulin the preferred treatment for HbA1c >9%?
  Zachary Bloomgarden
  Journal of Diabetes.2017; 9(9): 814.     CrossRef
• Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis
  Manuj Sharma, Nicholas Beckley, Irwin Nazareth, Irene Petersen
  BMJ Open.2017; 7(10): e017260.     CrossRef
• The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients
  Nasser Aghamohammadzadeh, Mitra Niafar, Elham Dalir Abdolahinia, Farzad Najafipour, Saeed Mohamadzadeh Gharebaghi, Khadijeh Adabi, Elaheh Dalir Abdolahinia, Hamidreza Ahadi
  Therapeutic Advances in Endocrinology and Metabolism.2015; 6(2): 56.     CrossRef
• Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1cwith Time
  Hye-jin Yoon, Yong-ho Lee, Kwang Joon Kim, So Ra Kim, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  BioMed Research International.2015; 2015: 1.     CrossRef
• Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study
  Eu Jeong Ku, Kyong Yeon Jung, Yoon Ji Kim, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Young Min Cho, Kyong Soo Park, Hak Chul Jang, Soo Lim, Bo Ahrén, Giorgio Sesti
  PLOS ONE.2015; 10(6): e0129477.     CrossRef
• Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
  Elena Pavlova Filipova, Katya Hristova Uzunova, Toni Yonkov Vekov
  Diabetology & Metabolic Syndrome.2015;[Epub]     CrossRef
• Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
  Sen Shi, Swayam Prakash Srivastava, Megumi Kanasaki, Jianhua He, Munehiro Kitada, Takako Nagai, Kyoko Nitta, Susumu Takagi, Keizo Kanasaki, Daisuke Koya
  Kidney International.2015; 88(3): 479.     CrossRef
• Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs
  L. H. Opie
  Cardiovascular Drugs and Therapy.2014; 28(4): 331.     CrossRef
• Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
  Dong-Lim Kim
  Diabetes & Metabolism Journal.2013; 37(6): 429.     CrossRef

Beyond statin therapy for reducing low density lipoprotein cholesterol (LDL-C), additional therapeutic strategies are required to achieve more optimal reduction in cardiovascular risk among diabetic patients with dyslipidemia. To evaluate the effects and the safety of combined treatment with omega-3 fatty acids and statin in dyslipidemic patients with type 2 diabetes, we conducted a randomized, open-label study in Korea. Patients with persistent hypertriglyceridemia (≥200 mg/dL) while taking statin for at least 6 weeks were eligible. Fifty-one patients were randomized to receive either omega-3 fatty acid 4, 2 g, or no drug for 8 weeks while continuing statin therapy. After 8 weeks of treatment, the mean percentage change of low density lipoprotein (LDL) particle size and triglyceride (TG) level was greater in patients who were prescribed 4 g of omega-3 fatty acid with statin than in patients receiving statin monotherapy (2.8%±3.1% vs. 2.3%±3.6%, P=0.024; -41.0%±24.1% vs. -24.2%±31.9%, P=0.049). Coadministration of omega-3 fatty acids with statin increased LDL particle size and decreased TG level in dyslipidemic patients with type 2 diabetes. The therapy was well tolerated without significant adverse effects.

Citations

Citations to this article as recorded by  

• Diabetic cardiac autonomic neuropathy: insulin resistance, lipid profile, and omega-3 polyunsaturated fatty acids
  Martin-Yurii Markevich, Volodymyr Segin, Victoria Serhiyenko, Alexandr Serhiyenko
  InterConf.2023; (35(163)): 213.     CrossRef
• Atherogenic features of the fatty acid profile of erythrocyte membranes of patients with fatty liver disease of mixed genesis
  M. V. Kruchinina, A. V. Belkovets, M. V. Parulikova, A. A. Gromov
  Ateroscleroz.2023; 19(4): 350.     CrossRef
• Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) – a review of clinical trials and cohort
  Vitoria Melo, Thomas Silva, Thaissa Silva, Juliana Freitas, Joselita Sacramento, Mirian Vazquez, Edilene Araujo
  Endocrine Regulations.2022; 56(1): 66.     CrossRef
• Nutrigenetics, omega-3 and plasma lipids/lipoproteins/apolipoproteins with evidence evaluation using the GRADE approach: a systematic review
  Justine Keathley, Véronique Garneau, Valérie Marcil, David M Mutch, Julie Robitaille, Iwona Rudkowska, Gabriela Magdalena Sofian, Sophie Desroches, Marie-Claude Vohl
  BMJ Open.2022; 12(2): e054417.     CrossRef
• N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial
  Gediz Dogay Us, Sohail Mushtaq
  Lipids in Health and Disease.2022;[Epub]     CrossRef
• The effect of omega-3 fatty acids and its combination with statins on lipid profile in patients with hypertriglyceridemia: A systematic review and meta-analysis of randomized controlled trials
  Yunjiao Yang, Wen Deng, Yanmei Wang, Tongyi Li, Yiding Chen, Cong Long, Qing Wen, Yue Wu, Qiu Chen
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Study of the Healthy Effects of Different Fat Ratios Mixtures of Omega-3 to Omega-6 in Male Mice with Alloxan-Induced Diabetes
  Ali. M. Atallah, Faryal. F. Hussein
  Tikrit Journal for Agricultural Sciences.2021; 21(4): 129.     CrossRef
• Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders
  Neha M. Chitre, Nader H. Moniri, Kevin S. Murnane
  CNS & Neurological Disorders - Drug Targets.2020; 18(10): 735.     CrossRef
• Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
  Ji Eun Jun, In-Kyung Jeong, Jae Myung Yu, Sung Rae Kim, In Kye Lee, Kyung-Ah Han, Sung Hee Choi, Soo-Kyung Kim, Hyeong Kyu Park, Ji-Oh Mok, Yong-ho Lee, Hyuk-Sang Kwon, So Hun Kim, Ho-Cheol Kang, Sang Ah Lee, Chang Beom Lee, Kyung Mook Choi, Sung-Ho Her,
  Diabetes & Metabolism Journal.2020; 44(1): 78.     CrossRef
• The combination of canagliflozin and omega-3 fatty acid ameliorates insulin resistance and cardiac biomarkersviamodulation of inflammatory cytokines in type 2 diabetic rats
  Mohammed Mohsen Safhi, Tarique Anwer, Gyas Khan, Rahimullah Siddiqui, Sivagurunathan Moni Sivakumar, Mohammad Firoz Alam
  The Korean Journal of Physiology & Pharmacology.2018; 22(5): 493.     CrossRef
• Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles
  C B Dias, N Amigo, L G Wood, X Correig, M L Garg
  European Journal of Clinical Nutrition.2017; 71(11): 1297.     CrossRef
• Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
  Tian Shen, Guoqiang Xing, Jingfen Zhu, Shuxian Zhang, Yong Cai, Donghua Li, Gang Xu, Evan Xing, Jianyu Rao, Rong Shi
  Lipids in Health and Disease.2017;[Epub]     CrossRef
• Effects of dietary saturated and n-6 polyunsaturated fatty acids on the incorporation of long-chain n-3 polyunsaturated fatty acids into blood lipids
  C B Dias, L G Wood, M L Garg
  European Journal of Clinical Nutrition.2016; 70(7): 812.     CrossRef
• Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea
  H.-S. Kim, H. Kim, Y. J. Jeong, S. J. Yang, S. J. Baik, H. Lee, S.-H. Lee, J. H. Cho, I.-Y. Choi, H. W. Yim, K.-H. Yoon
  Journal of Clinical Pharmacy and Therapeutics.2016; 41(5): 508.     CrossRef
• Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia
  Eugene Han, Yujung Yun, Gyuri Kim, Yong-ho Lee, Hye Jin Wang, Byung-Wan Lee, Bong Soo Cha, Beom Seok Kim, Eun Seok Kang, Wolf-Hagen Schunck
  PLOS ONE.2016; 11(5): e0154683.     CrossRef
• The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
  James Backes, Deborah Anzalone, Daniel Hilleman, Julia Catini
  Lipids in Health and Disease.2016;[Epub]     CrossRef
• Supercritical fluid extraction of grape seeds: extract chemical composition, antioxidant activity and inhibition of nitrite production in LPS-stimulated Raw 264.7 cells
  Concepción Pérez, María Luisa Ruiz del Castillo, Carmen Gil, Gracia Patricia Blanch, Gema Flores
  Food & Function.2015; 6(8): 2607.     CrossRef
• Omega-3 Polyunsaturated Fatty Acids May Attenuate Streptozotocin-Induced Pancreatic β-Cell Death via Autophagy Activation in Fat1 Transgenic Mice
  Won-Min Hwang, Dong-Ho Bak, Dong Ho Kim, Ju Young Hong, Seung-Yun Han, Keun-Young Park, Kyu Lim, Dong-Mee Lim, Jae Gu Kang
  Endocrinology and Metabolism.2015; 30(4): 569.     CrossRef
• Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: A review of the literature
  Matthew K. Ito
  Atherosclerosis.2015; 242(2): 647.     CrossRef
• Nutraceuticals and dyslipidaemia: Beyond the common therapeutics
  Pietro Scicchitano, Matteo Cameli, Maria Maiello, Pietro Amedeo Modesti, Maria Lorenza Muiesan, Salvatore Novo, Pasquale Palmiero, Pier Sergio Saba, Roberto Pedrinelli, Marco Matteo Ciccone
  Journal of Functional Foods.2014; 6: 11.     CrossRef
• The effect of dietary omega-3 polyunsaturated fatty acids on plasma lipids and lipoproteins of C57BL/6 mice is age and sex specific
  K.A. Balogun, R.S. Randunu, S.K. Cheema
  Prostaglandins, Leukotrienes and Essential Fatty Acids.2014; 91(1-2): 39.     CrossRef
• Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: a clinical trial
  Catherine Ouellette, Iwona Rudkowska, Simone Lemieux, Benoit Lamarche, Patrick Couture, Marie-Claude Vohl
  Lipids in Health and Disease.2014;[Epub]     CrossRef
• Saturated fat consumption may not be the main cause of increased blood lipid levels
  C.B. Dias, R. Garg, L.G. Wood, M.L. Garg
  Medical Hypotheses.2014; 82(2): 187.     CrossRef

Citations

Citations to this article as recorded by  

• Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
  Yifeng Xu, Yanxiang Wu, Qin Huang
  Archives of Gynecology and Obstetrics.2017; 296(4): 661.     CrossRef

Citations

Citations to this article as recorded by  

• Cancer biology in diabetes update: Focusing on antidiabetic drugs
  Emi Kawakita, Keizo Kanasaki
  Journal of Diabetes Investigation.2024; 15(5): 525.     CrossRef
• Pioglitazone, Bladder Cancer, and the Presumption of Innocence
  Georgios S. Papaetis
  Current Drug Safety.2022; 17(4): 294.     CrossRef
• A systematic review of observational studies of the association between pioglitazone use and bladder cancer
  E. Ripamonti, L. Azoulay, M. Abrahamowicz, R.W. Platt, S. Suissa
  Diabetic Medicine.2019; 36(1): 22.     CrossRef
• Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes
  Elizabeth M. Garry, John B. Buse, Mugdha Gokhale, Jennifer L. Lund, Matthew E. Nielsen, Virginia Pate, Til Stürmer
  Diabetes, Obesity and Metabolism.2019; 21(9): 2096.     CrossRef
• Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies
  Juha Mehtälä, Houssem Khanfir, Dimitri Bennett, Yizhou Ye, Pasi Korhonen, Fabian Hoti
  Diabetology International.2019; 10(1): 24.     CrossRef
• Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future
  Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay, Daniel Krewski
  Critical Reviews in Toxicology.2018; 48(1): 52.     CrossRef
• An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug’s effect on cardiovascular disease and non-alcoholic steatohepatitis
  Mayer B. Davidson, Deyu Pan
  Diabetes Research and Clinical Practice.2018; 135: 102.     CrossRef
• Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world data
  Mohammad Adil, Rashid Ali Khan, Pinaki Ghosh, Shiva Kumar Venkata, Amit Dattatraya Kandhare, Manju Sharma
  Clinical Epidemiology and Global Health.2018; 6(2): 61.     CrossRef
• Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
  Huilin Tang, Weilong Shi, Shuangshuang Fu, Tiansheng Wang, Suodi Zhai, Yiqing Song, Jiali Han
  Cancer Medicine.2018; 7(4): 1070.     CrossRef
• Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
  Hua Qu, Yi Zheng, Yuren Wang, Rui Zhang, Xiongzhong Ruan, Gangyi Yang, Zhenqi Liu, Hongting Zheng
  Scientific Reports.2017;[Epub]     CrossRef
• Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
  Elena Filipova, Katya Uzunova, Krassimir Kalinov, Toni Vekov
  Diabetes Therapy.2017; 8(4): 705.     CrossRef
• Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
  YOUHONG DONG, ANPING WANG
  Oncology Letters.2016; 12(1): 89.     CrossRef
• Ten‐year observational follow‐up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
  E. Erdmann, S. Harding, H. Lam, A. Perez
  Diabetes, Obesity and Metabolism.2016; 18(3): 266.     CrossRef
• Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evidence
  Mayer B. Davidson
  Journal of Diabetes and its Complications.2016; 30(6): 981.     CrossRef
• The current role of thiazolidinediones in diabetes management
  Christos V. Rizos, Anastazia Kei, Moses S. Elisaf
  Archives of Toxicology.2016; 90(8): 1861.     CrossRef
• Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review
  Saarwaani Vallabhajosyula, Shashaank Vallabhajosyula, Saraschandra Vallabhajosyula, Suma Nair, Asha Kamath, Karthik N. Rao
  Medical Journal Armed Forces India.2016; 72(3): 253.     CrossRef
• Baseline glycemic status and mortality in 241,499 Korean metropolitan subjects: A Kangbuk Samsung Health Study
  Eun-Jung Rhee, Se Eun Park, Yoosoo Chang, Seungho Ryu, Won-Young Lee
  Metabolism.2016; 65(2): 68.     CrossRef
• Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
  Eugene Han, Suk-Yong Jang, Gyuri Kim, Yong-ho Lee, Eun Yeong Choe, Chung Mo Nam, Eun Seok Kang
  Medicine.2016; 95(6): e2786.     CrossRef
• Polemics of pioglitazone: an appraisal in 2015
  Awadhesh Kumar Singh
  Expert Review of Endocrinology & Metabolism.2015; 10(4): 447.     CrossRef
• Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
  Daniel Levin, Samira Bell, Reijo Sund, Sirpa A. Hartikainen, Jaakko Tuomilehto, Eero Pukkala, Ilmo Keskimäki, Ellena Badrick, Andrew G. Renehan, Iain E. Buchan, Samantha L. Bowker, Jasjeet K. Minhas-Sandhu, Zafar Zafari, Carlo Marra, Jeffrey A. Johnson, B
  Diabetologia.2015; 58(3): 493.     CrossRef
• Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta‐analysis
  Richard M. Turner, Chun S. Kwok, Chen Chen‐Turner, Chinedu A. Maduakor, Sonal Singh, Yoon K. Loke
  British Journal of Clinical Pharmacology.2014; 78(2): 258.     CrossRef
• A Review on Thiazolidinediones and Bladder Cancer in Human Studies
  Chin-Hsiao Tseng
  Journal of Environmental Science and Health, Part C.2014; 32(1): 1.     CrossRef
• Physiological Functions of Peroxisome Proliferator-Activated Receptor β
  Jaap G. Neels, Paul A. Grimaldi
  Physiological Reviews.2014; 94(3): 795.     CrossRef
• Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study
  Sang-Man Jin, Sun Ok Song, Chang Hee Jung, Jin-Sun Chang, Sunghwan Suh, Seung Min Kang, Inkyung Jung, Cheol-Young Park, Jae Hyeon Kim, Jae Hyoung Cho, Byung-Wan Lee
  Journal of Korean Medical Science.2014; 29(2): 238.     CrossRef
• Pioglitazone
  SS Jadhav, VK Shivane, AR Lila, TR Bandgar, NS Shah
  Journal of Postgraduate Medicine.2014; 60(3): 293.     CrossRef
• Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes
  Hannah Seok, Bong Soo Cha
  Diabetes & Metabolism Journal.2013; 37(5): 326.     CrossRef
• Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report
  Hirofumi Suzuki, Masaya Sakamoto, Takeshi Hayashi, Hiroyuki Iuchi, Kennosuke Ohashi, Tsuyoshi Isaka, Noriko Sakamoto, Yosuke Kayama, Katsuyoshi Tojo, Michihiro Yoshimura, Kazunori Utsunomiya
  Cardiovascular Diabetology.2013;[Epub]     CrossRef
• The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
  Hanford Yau, Kathya Rivera, Romina Lomonaco, Kenneth Cusi
  Current Diabetes Reports.2013; 13(3): 329.     CrossRef
• Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J2012;36:371-8)
  Sheyu Li, Haoming Tian
  Diabetes & Metabolism Journal.2013; 37(1): 81.     CrossRef
• Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m2: A Surgeon’s Perspective
  Ricardo Cohen, Pedro Paulo Caravatto, Tarissa Petry
  Obesity Surgery.2013; 23(6): 809.     CrossRef

The conventional glycemic indices used in management of diabetic patients includes A1c, fructosamine, 1,5-anhydroglucitol, and glycated albumin (GA). Among these indices, A1c is currently used as the gold standard. However, A1c cannot reflect the glycemic change over a relatively short period of time, and its accuracy is known to decrease when abnormalities in hemoglobin metabolism, such as anemia, coexist. When considering these weaknesses, there have been needs for finding a novel glycemic index for diagnosing and managing diabetes, as well as for predicting diabetic complications properly. Recently, several studies have suggested the potential of GA as an intermediate-term glycation index in covering the short-term effect of treatment. Furthermore, its role as a pathogenic protein affecting the worsening of diabetes and occurrence of diabetic complications is receiving attention as well. Therefore, in this article, we wanted to review the recent status of GA as a glycemic index and as a pathogenic protein.

Citations

Citations to this article as recorded by  

• Simultaneous electrochemical detection of glycated and human serum albumin for diabetes management
  Monalisha Ghosh Dastidar, Krishnan Murugappan, David R. Nisbet, Antonio Tricoli
  Biosensors and Bioelectronics.2024; 246: 115876.     CrossRef
• Insights into the conformational, secondary structural, dynamical and hydration pattern changes of glucose mediated glycated HSA: a molecular dynamics approach
  Jayanth Jeevanandam, N. Arul Murugan, N. T. Saraswathi
  Journal of Biomolecular Structure and Dynamics.2024; : 1.     CrossRef
• Association of the Ratio of Glycoalbumin to Hemoglobin A1c With Season Change and the COVID-19 Pandemic in Patients With Type 2 Diabetes Mellitus
  Kohzo Takebayashi, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Koshi Hashimoto
  Cureus.2024;[Epub]     CrossRef
• Glucose metabolism and smaller hippocampal volume in elderly people with normal cognitive function
  Ayano Shima, Moeko Noguchi-Shinohara, Shutaro Shibata, Yuta Usui, Yasuko Tatewaki, Benjamin Thyreau, Jun Hata, Tomoyuki Ohara, Takanori Honda, Yasuyuki Taki, Shigeyuki Nakaji, Tetsuya Maeda, Masaru Mimura, Kenji Nakashima, Jun-ichi Iga, Minoru Takebayashi
  npj Aging.2024;[Epub]     CrossRef
• Inverse correlation of free triiodothyronine with glycated albumin and the glycated albumin/glycated hemoglobin ratio in hemodialysis patients: a cross-sectional study
  Keiji Mimura, Takahiro Nishide, Toshihide Naganuma, Yui Katsube, Seiji Ishitani, Katsuhiko Nakahara, Naohisa Hirasaka, Rie Mizobata, Yuko Yamagata, Osamu Nishikawa, Susumu Yukawa
  Renal Replacement Therapy.2023;[Epub]     CrossRef
• Correlation Analysis of Serum Glycated Albumin, Homocysteine Levels and the Severity of Acute Cerebral Infarction
  丽娅 陈
  Advances in Clinical Medicine.2023; 13(04): 6738.     CrossRef
• Conformational variation of site specific glycated albumin: A Molecular dynamics approach
  Jayanth Jeevanandam, V. L. S. Prasad Burra, N.T. Saraswathi
  Computers in Biology and Medicine.2023; 164: 107276.     CrossRef
• Multiple cardiometabolic diseases enhance the adverse effects of hypoalbuminemia on mortality among centenarians in China: a cohort study
  Haowei Li, Shengshu Wang, Shanshan Yang, Shaohua Liu, Yang Song, Shimin Chen, Xuehang Li, Zhiqiang Li, Rongrong Li, Yali Zhao, Qiao Zhu, Chaoxue Ning, Miao Liu, Yao He
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer’s Disease: The JPSC-AD Study
  Moeko Noguchi-Shinohara, Sohshi Yuki-Nozaki, Chiemi Abe, Ayaka Mori, Mai Horimoto, Masami Yokogawa, Natsuko Ishida, Yukio Suga, Junko Ishizaki, Mai Ishimiya, Hiroyuki Nakamura, Kiyonobu Komai, Hiroyuki Nakamura, Mao Shibata, Tomoyuki Ohara, Jun Hata, Tosh
  Journal of Alzheimer's Disease.2022; 85(1): 235.     CrossRef
• Albumin Glycation Affects the Delivery of C-Peptide to the Red Blood Cells
  Monica J. Jacobs, Morgan K. Geiger, Suzanne E. Summers, Charles P. DeLuca, Kurt R. Zinn, Dana M. Spence
  ACS Measurement Science Au.2022; 2(3): 278.     CrossRef
• Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
  Jeongseon Yoo, Youngah Choi, Shin Ae Park, Ji Yeon Seo, Chul Woo Ahn, Jaehyun Han
  Journal of Clinical Medicine.2022; 11(9): 2327.     CrossRef
• Antioxidant and inflammatory biomarkers in herpes zoster
  Tuba Oskay, Cem Keskin, Mehmet Özen
  Journal of Medical Virology.2022; 94(8): 3924.     CrossRef
• The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response
  Vitarani Dwi Ananda Ningrum, Ahmad Hamim Sadewa, Zullies Ikawati, Rika Yuliwulandari, M. Robikhul Ikhsan, Rohmatul Fajriyah, Santosh K. Patnaik
  PLOS ONE.2022; 17(7): e0271410.     CrossRef
• Glycated albumin is associated with all-cause and cardiovascular mortality among U.S. adults with and without diabetes: A retrospective cohort study
  Stefano Ciardullo, Federico Rea, Gianluca Perseghin
  Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(10): 2375.     CrossRef
• Comparative evaluation of antioxidant, antiglycation and α-glucosidase inhibitory potential of some indigenous medicinal Trigonella species
  Namdeo Gaonkar, Rakhee Dangi
  Vegetos.2022; 36(4): 1337.     CrossRef
• Aptamer-Based Glycated Albumin Sensor for Capacitive Spectroscopy
  Toshiya Sakata, Reiko Shiratori, Shoichi Nishitani
  Analytical Chemistry.2022;[Epub]     CrossRef
• Correlation between glycosylated serum albumin and glycosylated haemoglobin in the southwest Chinese population: Establishment of a regression model
  Li-Rui Kong, Yan Zhang, Feng Wu, Xue-Qin Wen, Da-Hai He, Chao-Qiong Zhou, Lin Wang
  Journal of Diabetes and its Complications.2021; 35(2): 107796.     CrossRef
• Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
  Xiaojing Feng, Yanyi Yang, Siqi Zhuang, Yiyuan Fang, Yufeng Dai, Yaoyang Fu, Qian Hu, Qianqin Yuan, Haoneng Tang, Lingli Tang
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Pre-Stroke Glycemic Variability Estimated by Glycated Albumin Is Associated with Early Neurological Deterioration and Poor Functional Outcome in Prediabetic Patients with Acute Ischemic Stroke
  Sang-Hwa Lee, Yerim Kim, So Young Park, Chulho Kim, Yeo Jin Kim, Jong-Hee Sohn
  Cerebrovascular Diseases.2021; 50(1): 26.     CrossRef
• Detection of Glycated Albumin Using a Novel Field Effect Aptasensor
  Mahdi Sasar, Azad Farzadfard, Yaser Abdi, Mehran Habibi-Rezaei
  IEEE Sensors Journal.2020; 20(18): 10387.     CrossRef
• Elevated serum glycated albumin and glycated albumin : hemoglobin A1c ratio were associated with hippocampal atrophy in a general elderly population of Japanese: The Hisayama Study
  Tomoyuki Ohara, Yoshihiko Furuta, Naoki Hirabayashi, Jun Hata, Yoichiro Hirakawa, Takanori Honda, Daigo Yoshida, Mao Shibata, Takanari Kitazono, Toshiharu Ninomiya
  Journal of Diabetes Investigation.2020; 11(4): 971.     CrossRef
• Effect of Prestroke Glycemic Variability Estimated Glycated Albumin on Stroke Severity and Infarct Volume in Diabetic Patients Presenting With Acute Ischemic Stroke
  Sang-Hwa Lee, Min Uk Jang, Yerim Kim, So Young Park, Chulho Kim, Yeo Jin Kim, Jong-Hee Sohn
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Association between serum glycated albumin and risk of cardiovascular disease in a Japanese community: The Hisayama Study
  Akane Mihara, Tomoyuki Ohara, Jun Hata, Takanori Honda, Sanmei Chen, Satoko Sakata, Emi Oishi, Yoichiro Hirakawa, Tomohiro Nakao, Takanari Kitazono, Toshiharu Ninomiya
  Atherosclerosis.2020; 311: 52.     CrossRef
• Low Antioxidant Status of Serum Uric Acid, Bilirubin, Albumin, and Creatinine in Patients With Benign Paroxysmal Positional Vertigo
  Ke-Hang Xie, Ling-Ling Liu, Chu-Yin Su, Xiao-Feng Huang, Bao-Xing Wu, Run-Ni Liu, Hua Li, Qing-Qing Chen, Jia-Sheng He, Yong-Kun Ruan
  Frontiers in Neurology.2020;[Epub]     CrossRef
• A Comparison of Biomarkers in the Assessment of Glycemic Control in Diabetes: Reviewing the Evidence
  Aga S. Sameer, Mujeeb Z. Banday, Saniya Nissar, Sheikh A. Saeed
  Current Diabetes Reviews.2019; 15(6): 471.     CrossRef
• Evaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
  Libo Liang, He He, Yuping Zeng, Mei Zhang, Xia Wang, Xiaoling Li, Shanshan Liang, Zhenmei An, Hengjian Huang
  Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
• The association between skin auto-fluorescence of palmoplantar sites and microvascular complications in Asian patients with type 2 diabetes mellitus
  Jong Jin Kim, Bosu Jeong, Yongin Cho, Mi-hyang Kwon, Yong-ho Lee, Uk Kang, Eun Seok Kang
  Scientific Reports.2018;[Epub]     CrossRef
• Hemoglobin A1c, Not Glycated Albumin, Can Independently Reflect the Ankylosing Spondylitis Disease Activity Score
  Sejin Byun, Seung Min Jung, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee
  Journal of Rheumatic Diseases.2018; 25(2): 131.     CrossRef
• Albumin Abundance and Its Glycation Status Determine Hemoglobin Glycation
  Mashanipalya G. Jagadeeshaprasad, Vinashya Venkatasubramani, Ambika G. Unnikrishnan, Mahesh J. Kulkarni
  ACS Omega.2018; 3(10): 12999.     CrossRef
• The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges
  Ting Gan, Baoying Liao, Gaosi Xu
  Journal of Diabetes and its Complications.2018; 32(9): 876.     CrossRef
• Influences of Anemia, Kidney Disease, Thyroid Dysfunction, and Liver Disease on the Ratio of Glycated Albumin to Hemoglobin A1c
  Hiroyasu Miyamoto, Xinran Tao, Takuji Kohzuma, Akihiro Ohnishi
  Journal of Diabetes Science and Technology.2018; 12(5): 1082.     CrossRef
• Glycated albumin increases with disease activity in rheumatoid factor positive rheumatoid arthritis patients with normal fasting glucose and HbA1c
  Jin-Su Park, Jungsik Song, Yong-Beom Park, Soo-Kon Lee, Sang-Won Lee
  Joint Bone Spine.2017; 84(1): 115.     CrossRef
• Variability in glycated albumin levels predicts the progression of diabetic nephropathy
  Su Bin Park, Sang Soo Kim, In Joo Kim, Yoon Jeong Nam, Kang Hee Ahn, Jong Ho Kim, Yun Kyung Jeon, Bo Hyun Kim, Sang Heon Song, Ihm Soo Kwak, Eun Kyung Lee, Yong Ki Kim
  Journal of Diabetes and its Complications.2017; 31(6): 1041.     CrossRef
• Alternative Measures of Hyperglycemia and Risk of Alzheimer’s Disease in the Community: The Hisayama Study
  Naoko Mukai, Tomoyuki Ohara, Jun Hata, Yoichiro Hirakawa, Daigo Yoshida, Hiro Kishimoto, Masafumi Koga, Udai Nakamura, Takanari Kitazono, Yutaka Kiyohara, Toshiharu Ninomiya
  The Journal of Clinical Endocrinology & Metabolism.2017; 102(8): 3002.     CrossRef
• Chicken albumin exhibits natural resistance to glycation
  Jessica Zuck, Chad R. Borges, Eldon J Braun, Karen L Sweazea
  Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology.2017; 203: 108.     CrossRef
• Variations in native protein glycation and plasma antioxidants in several birds of prey
  Tana Ingram, Jessica Zuck, Chad R. Borges, Patrick Redig, Karen L. Sweazea
  Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology.2017; 210: 18.     CrossRef
• Glycated albumin: from biochemistry and laboratory medicine to clinical practice
  Elena Dozio, Nicola Di Gaetano, Peter Findeisen, Massimiliano Marco Corsi Romanelli
  Endocrine.2017; 55(3): 682.     CrossRef
• Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus
  Chan-Hee Jung, Bora Lee, Dug-Hyun Choi, Sang-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang, Ji-Oh Mok
  Diabetes Research and Clinical Practice.2017; 125: 53.     CrossRef
• Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus
  Nana Wang, Zhen Xu, Ping Han, Tiegang Li
  Diabetes/Metabolism Research and Reviews.2017;[Epub]     CrossRef
• Importance of glycemic control in cancer patients with diabetes: Treatment through end of life
  Denise S Hershey
  Asia-Pacific Journal of Oncology Nursing.2017; 4(4): 313.     CrossRef
• The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus
  Won Seon Jeon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Cheol-Young Park
  Diabetes Research and Clinical Practice.2016; 116: 46.     CrossRef
• Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study
  Ju-Ming Lu, Li-Nong Ji, Yu-Feng Li, Quan-Min Li, Shan-Shan Lin, Xiao-Feng Lv, Li Wang, Yuan Xu, Xiao-Hui Guo, Qi-Yu Guo, Li Ma, Jin Du, Ying-Li Chen, Cui-Ling Zhao, Qiu-Lan Zhang, Qi-Mei She, Xiu-Min Jiao, Mei-Hua Lu, Rong-Qing Pan, Ying Gao
  Journal of Diabetes and its Complications.2016; 30(8): 1609.     CrossRef
• HCD Fragmentation of Glycated Peptides
  Eva C. Keilhauer, Philipp E. Geyer, Matthias Mann
  Journal of Proteome Research.2016; 15(8): 2881.     CrossRef
• Glycated albumin indicates peripheral diabetic neuropathy
  Nana Wang, Chuanji Guo, Ping Han, Tiegang Li
  Acta Diabetologica.2016; 53(6): 973.     CrossRef
• Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes
  Xueying Tan, Jingbo Hu
  Expert Opinion on Pharmacotherapy.2016; 17(9): 1285.     CrossRef
• Change in serum albumin concentration is inversely and independently associated with risk of incident metabolic syndrome
  Sang-Man Jin, Yong Joo Hong, Jae Hwan Jee, Ji Cheol Bae, Kyu Yeon Hur, Moon-Kyu Lee, Jae Hyeon Kim
  Metabolism.2016; 65(11): 1629.     CrossRef
• Plasma Glycated Albumin Levels Clearly Detect Hearing Loss and Atherosclerosis in Patients with Impaired Fasting Glucose
  Hande Ezerarslan, Tuba Çandar, Sedat Özdemir, Gökçe Kaan Ataç, Sinan Kocatürk
  Medical Principles and Practice.2016; 25(4): 309.     CrossRef
• Glycation of Nail Proteins: From Basic Biochemical Findings to a Representative Marker for Diabetic Glycation-Associated Target Organ Damage
  Antoine Sadiki Kishabongo, Philippe Katchunga, Elisabeth H. Van Aken, Reinhart Speeckaert, Sabrina Lagniau, Renaat Coopman, Marijn M. Speeckaert, Joris R. Delanghe, Frederique Lisacek
  PLOS ONE.2015; 10(3): e0120112.     CrossRef
• A randomized, double‐blind, placebo‐controlled, phase II clinical trial to investigate the efficacy and safety of oral DA‐1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise
  Chang Hee Jung, Cheol‐Young Park, Kyu‐Joeng Ahn, Nan‐Hee Kim, Hak‐Chul Jang, Moon‐Kyu Lee, Joong‐Yeol Park, Choon‐Hee Chung, Kyung‐Wan Min, Yeon‐Ah Sung, Jeong‐Hyun Park, Sung Jin Kim, Hyo Jung Lee, Sung‐Woo Park
  Diabetes/Metabolism Research and Reviews.2015; 31(3): 295.     CrossRef
• Salivary Protein Glycosylation as a Noninvasive Biomarker for Assessment of Glycemia
  Paturi V. Rao, Amber Laurie, Eric S. Bean, Charles T. Roberts, Srinivasa R. Nagalla
  Journal of Diabetes Science and Technology.2015; 9(1): 97.     CrossRef
• Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1cwith Time
  Hye-jin Yoon, Yong-ho Lee, Kwang Joon Kim, So Ra Kim, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  BioMed Research International.2015; 2015: 1.     CrossRef
• Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
  Hye-jin Yoon, Yong-ho Lee, So Ra Kim, Tyler Hyungtaek Rim, Eun Young Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  Cardiovascular Diabetology.2015;[Epub]     CrossRef
• Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study
  Naoko Mukai, Toshiharu Ninomiya, Jun Hata, Yoichiro Hirakawa, Fumie Ikeda, Masayo Fukuhara, Taeko Hotta, Masafumi Koga, Udai Nakamura, Dongchon Kang, Takanari Kitazono, Yutaka Kiyohara
  Cardiovascular Diabetology.2015;[Epub]     CrossRef
• Recent Topics in Chemical and Clinical Research on Glycated Albumin
  Yuki Ueda, Hideyuki Matsumoto
  Journal of Diabetes Science and Technology.2015; 9(2): 177.     CrossRef
• Glycated albumin triggers fibrosis and apoptosis via an NADPH oxidase/Nox4-MAPK pathway-dependent mechanism in renal proximal tubular cells
  Weiwei Qi, Jianying Niu, Qiaojing Qin, Zhongdong Qiao, Yong Gu
  Molecular and Cellular Endocrinology.2015; 405: 74.     CrossRef
• The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status
  Ji Hye Huh, Kwang Joon Kim, Byung-Wan Lee, Dong Wook Kim, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Marta Letizia Hribal
  PLoS ONE.2014; 9(2): e89478.     CrossRef
• Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy
  Denise M. Scholtens, Michael J. Muehlbauer, Natalie R. Daya, Robert D. Stevens, Alan R. Dyer, Lynn P. Lowe, Boyd E. Metzger, Christopher B. Newgard, James R. Bain, William L. Lowe
  Diabetes Care.2014; 37(1): 158.     CrossRef
• Development of Magnetic Particle-Based Immunoassays and Their Applications in Diabetes Monitoring
  Cheng-Tai Chen, Chien-An Chen, Yu-Yin Tsai, Yi-Yen Yuan, Yi-Chau Huang, Ting-Shou Chen, Jane SC Tsai
  IEEE Transactions on Magnetics.2014; 50(1): 1.     CrossRef
• Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study
  Francesco Finamore, Feliciano Priego-Capote, Florent Gluck, Anne Zufferey, Pierre Fontana, Jean-Charles Sanchez
  EuPA Open Proteomics.2014; 3: 100.     CrossRef
• Development of an HbA1c-Based Conversion Equation for Estimating Glycated Albumin in a Korean Population with a Wide Range of Glucose Intolerance
  Chang Hee Jung, You-Cheol Hwang, Kwang Joon Kim, Bong Soo Cha, Cheol-Young Park, Won Seon Jeon, Jae Hyeon Kim, Sang-Man Jin, Sang Youl Rhee, Jeong-taek Woo, Byung-Wan Lee, Sompop Bencharit
  PLoS ONE.2014; 9(4): e95729.     CrossRef
• The Glycated Albumin to Glycated Hemoglobin Ratio Might Not Be Associated with Carotid Atherosclerosis in Patients with Type 1 Diabetes
  Wonjin Kim, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
  Diabetes & Metabolism Journal.2014; 38(6): 456.     CrossRef
• Optimal glycated albumin cutoff value to diagnose diabetes in Korean adults: A retrospective study based on the oral glucose tolerance test
  You-Cheol Hwang, Chang Hee Jung, Hong-Yup Ahn, Won Seon Jeon, Sang-Man Jin, Jeong-taek Woo, Bong Soo Cha, Jae Hyeon Kim, Cheol-Young Park, Byung-Wan Lee
  Clinica Chimica Acta.2014; 437: 1.     CrossRef
• Inverse Association between Glycated Albumin and Insulin Secretory Function May Explain Higher Levels of Glycated Albumin in Subjects with Longer Duration of Diabetes
  Yong-ho Lee, Mi Hyang Kown, Kwang Joon Kim, Eun Young Lee, Daham Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Marià Alemany
  PLoS ONE.2014; 9(9): e108772.     CrossRef
• Serum glycated albumin predicts the progression of diabetic retinopathy—a five year retrospective longitudinal study
  Jiemin Pan, Qing Li, Lei Zhang, Lili Jia, Junling Tang, Yuqian Bao, Weiping Jia
  Journal of Diabetes and its Complications.2014; 28(6): 772.     CrossRef
• Astragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells
  Weiwei Qi, Jianying Niu, Qiaojing Qin, Zhongdong Qiao, Yong Gu
  Cell Stress and Chaperones.2014; 19(1): 105.     CrossRef
• The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
  Eun Yeong Choe, Yongin Cho, Younjeong Choi, Yujung Yun, Hye Jin Wang, Obin Kwon, Byung-Wan Lee, Chul Woo Ahn, Bong Soo Cha, Hyun Chul Lee, Eun Seok Kang
  Diabetes & Metabolism Journal.2014; 38(3): 211.     CrossRef
• The Ratio of Estimated Average Glucose to Fasting Plasma Glucose Level Is Superior to Glycated Albumin, Hemoglobin A1c, Fructosamine, and GA/A1c Ratio for Assessingβ-Cell Function in Childhood Diabetes
  Ji Eun Lee, Ji Woo Lee, Tatsuyoshi Fujii, Noriyoshi Fujii, Jong Weon Choi
  BioMed Research International.2014; 2014: 1.     CrossRef
• Glycated albumin and HbA1c as predictors of mortality and vascular complications in type 2 diabetes patients with normal and moderately impaired renal function: 5-year results from a 380 patient cohort
  Christoph Hasslacher, Felix Kulozik, Isabel Platten, Justo Lorenzo Bermejo
  Journal of Diabetes Research and Clinical Metabolism.2014; 3(1): 9.     CrossRef
• Angiotensin-(1–7) decreases glycated albumin-induced endothelial interleukin-6 expression via modulation of miR-146a
  Huang-Joe Wang, Wan-Yu Lo, Li-Jen Lin
  Biochemical and Biophysical Research Communications.2013; 430(3): 1157.     CrossRef
• Glycated Albumin Causes Pancreatic β-Cells Dysfunction Through Autophagy Dysfunction
  Young Mi Song, Sun Ok Song, Young-Hye You, Kun-Ho Yoon, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Ji-Won Kim, Byung-Wan Lee
  Endocrinology.2013; 154(8): 2626.     CrossRef
• Glycated albumin and diabetes mellitus
  Norihiro Furusyo, Jun Hayashi
  Biochimica et Biophysica Acta (BBA) - General Subjects.2013; 1830(12): 5509.     CrossRef
• Le proteine glicosilate nel diabete
  Roberto Testa, Anna Rita Bonfigli
  La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.2013; 9(4): 218.     CrossRef
• Serum glycated albumin predicts the progression of carotid arterial atherosclerosis
  Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
  Atherosclerosis.2012; 225(2): 450.     CrossRef
• Predicting Outcomes and Assessing Control with Alternate Glycemic Markers
  Kathleen M. Dungan
  Diabetes Technology & Therapeutics.2012; 14(9): 749.     CrossRef

Citations

Citations to this article as recorded by  

• Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
  Sejeong Lee, Jaehyun Bae, Doo Ri Jo, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Postprandial lipaemia following consumption of a meal enriched with medium chain saturated and/or long chain omega-3 polyunsaturated fatty acids. A randomised cross-over study
  Grace Austin, Jessica JA. Ferguson, Rohith N. Thota, Harjinder Singh, Tracy Burrows, Manohar L. Garg
  Clinical Nutrition.2021; 40(2): 420.     CrossRef
• Effects of fatty acids composition in a breakfast meal on the postprandial lipid responses: a systematic review and meta-analysis of randomised controlled trials
  Yuanhang Yao, Sheri Xueqi Pek, Darel Wee Kiat Toh, Xuejuan Xia, Jung Eun Kim
  International Journal of Food Sciences and Nutrition.2020; 71(7): 793.     CrossRef
• The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
  Pratik B Sandesara, Salim S Virani, Sergio Fazio, Michael D Shapiro
  Endocrine Reviews.2019; 40(2): 537.     CrossRef
• Determinant of postprandial triglyceride levels in healthy young adults
  Tri J.E. Tarigan, Anandhara I. Khumaedi, Syahidatul Wafa, Michael Johan, Murdani Abdullah, Ingrid S. Surono, Dicky L. Tahapary
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(3): 1917.     CrossRef
• Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins
  Motoki Yamashita, Atsushi Iwata, Yuta Kato, Makito Futami, Satoshi Imaizumi, Takashi Kuwano, Amane Ike, Makoto Sugihara, Hiroaki Nishikawa, Bo Zhang, Shin’ichiro Yasunaga, Keijiro Saku, Shin-ichiro Miura
  Heart and Vessels.2018; 33(10): 1175.     CrossRef
• Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals
  Haseeb A. Khan, Samia H. Sobki, Aishah Ekhzaimy, Isra Khan, Mona A. Almusawi
  Saudi Journal of Biological Sciences.2018; 25(8): 1729.     CrossRef
• Postprandial C‐peptide to glucose ratio as a predictor of β‐cell function and its usefulness for staged management of type 2 diabetes
  Eun Young Lee, Sena Hwang, Seo Hee Lee, Yong‐ho Lee, A Ra Choi, Youngki Lee, Byung‐Wan Lee, Eun Seok Kang, Chul Woo Ahn, Bong Soo Cha, Hyun Chul Lee
  Journal of Diabetes Investigation.2014; 5(5): 517.     CrossRef
• Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease
  Robert S. Rosenson, Michael H. Davidson, Benjamin J. Hirsh, Sekar Kathiresan, Daniel Gaudet
  Journal of the American College of Cardiology.2014; 64(23): 2525.     CrossRef
• The effect of insulin resistance on postprandial triglycerides in Korean type 2 diabetic patients
  Kyeong Hye Park, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
  Acta Diabetologica.2014; 51(1): 15.     CrossRef
• Acute effects of an oral supplement of (−)-epicatechin on postprandial fat and carbohydrate metabolism in normal and overweight subjects
  Gabriela Gutiérrez-Salmeán, Pilar Ortiz-Vilchis, Claudia M. Vacaseydel, Ivan Rubio-Gayosso, Eduardo Meaney, Francisco Villarreal, Israel Ramírez-Sánchez, Guillermo Ceballos
  Food & Function.2014; 5(3): 521.     CrossRef
• A comparative study of broccoli sprouts powder and standard triple therapy on cardiovascular risk factors following H.pylori eradication: a randomized clinical trial in patients with type 2 diabetes
  Parvin Mirmiran, Zahra Bahadoran, Mahdieh Golzarand, Homayoun Zojaji, Fereidoun Azizi
  Journal of Diabetes & Metabolic Disorders.2014;[Epub]     CrossRef
• Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension
  Chang FANG, Juan LEI, Shu-xian ZHOU, Yu-ling ZHANG, Gui-yi YUAN, Jing-feng WANG
  Chinese Medical Journal.2013; 126(4): 646.     CrossRef
• Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance
  Hyun Kim, Kwang Kim, Hye-Jeong Lee, Hee Yu, Jae Moon, Eun Kang, Bong Cha, Hyun Lee, Byung-Wan Lee, Young Kim
  Cardiovascular Diabetology.2012; 11(1): 83.     CrossRef